PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)
Clinical trial NCT01891643 · TERMINATED
Trial details
- NCT number
- NCT01891643
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-30
- Primary completion
- 2020-06-25
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.